Dr Reddy's Laboratories Pre-Tax Profit Margin 2010-2024 | RDY

Current and historical pre-tax profit margin for Dr Reddy's Laboratories (RDY) from 2010 to 2024. Pre-tax profit margin can be defined as earnings before taxes as a portion of total revenue. Dr Reddy's Laboratories pre-tax profit margin for the three months ending September 30, 2024 was .
Dr Reddy's Laboratories Pre-Tax Profit Margin Historical Data
Date TTM Revenue TTM Pre-Tax Income Pre-Tax Margin
2024-09-30 $3.58B $0.86B 24.08%
2024-06-30 $3.45B $0.86B 25.01%
2024-03-31 $3.35B $0.86B 25.73%
2023-12-31 $3.23B $0.82B 25.43%
2023-09-30 $3.19B $0.80B 25.12%
2023-06-30 $3.15B $0.77B 24.52%
2023-03-31 $2.99B $0.73B 24.50%
2022-12-31 $2.95B $0.61B 20.68%
2022-09-30 $2.83B $0.54B 19.09%
2022-06-30 $2.82B $0.51B 18.09%
2022-03-31 $2.83B $0.43B 15.07%
2021-12-31 $2.83B $0.49B 17.40%
2021-09-30 $2.79B $0.40B 14.35%
2021-06-30 $2.67B $0.35B 12.92%
2021-03-31 $2.59B $0.36B 13.92%
2020-12-31 $2.38B $0.35B 14.84%
2020-09-30 $2.32B $0.24B 10.34%
2020-06-30 $2.34B $0.23B 9.94%
2020-03-31 $2.32B $0.24B 10.36%
2019-12-31 $2.46B $0.25B 10.03%
2019-09-30 $2.38B $0.40B 16.90%
2019-06-30 $2.24B $0.38B 16.79%
2019-03-31 $2.23B $0.33B 14.65%
2018-12-31 $2.15B $0.29B 13.61%
2018-09-30 $2.20B $0.30B 13.77%
2018-06-30 $2.21B $0.28B 12.66%
2018-03-31 $2.18B $0.22B 10.04%
2017-12-31 $2.26B $0.22B 9.72%
2017-09-30 $2.22B $0.22B 9.68%
2017-06-30 $2.21B $0.21B 9.66%
2017-03-31 $2.17B $0.23B 10.41%
2016-12-31 $2.09B $0.20B 9.57%
2016-09-30 $2.15B $0.23B 10.62%
2016-06-30 $2.22B $0.31B 13.95%
2016-03-31 $2.34B $0.41B 17.56%
2015-12-31 $2.43B $0.47B 19.35%
2015-09-30 $2.44B $0.49B 19.95%
2015-06-30 $2.40B $0.46B 19.16%
2015-03-31 $2.40B $0.45B 18.86%
2014-12-31 $2.36B $0.47B 20.00%
2014-09-30 $2.32B $0.48B 20.77%
2014-06-30 $2.27B $0.49B 21.55%
2014-03-31 $2.17B $0.44B 20.45%
2013-12-31 $2.20B $0.47B 21.46%
2013-09-30 $2.15B $0.42B 19.40%
2013-06-30 $2.16B $0.40B 18.59%
2013-03-31 $2.14B $0.40B 18.63%
2012-12-31 $2.05B $0.34B 16.43%
2012-09-30 $2.05B $0.40B 19.32%
2012-06-30 $1.96B $0.37B 18.80%
2012-03-31 $1.95B $0.36B 18.56%
2011-12-31 $1.88B $0.38B 20.15%
2011-09-30 $1.78B $0.30B 16.71%
2011-06-30 $1.74B $0.29B 16.43%
2011-03-31 $1.66B $0.28B 16.81%
2010-12-31 $1.57B $0.24B 15.14%
2010-09-30 $1.52B $0.05B 2.96%
2010-06-30 $1.48B $0.03B 2.23%
2010-03-31 $1.50B $0.05B 3.06%
2009-12-31 $1.53B $-0.20B -13.37%
Sector Industry Market Cap Revenue
Medical Medical - Generic Drugs $11.677B $3.350B
Dr. Reddy's Laboratories Ltd. is an integrated global pharmaceutical company engaged in providing affordable and innovative medicines since 1984. The company markets its products in countries like the U.S., the UK, Germany, India, Russia, Venezuela, Romania and South Africa. Dr. Reddy's operates through three segments: Global Generics comprising unbranded prescription drugs along with over-the-counter drugs. It includes the operations of the company's biologics business. Pharmaceutical Services & Active Ingredients (PSAI) comprising active pharmaceutical ingredients (API) and custom pharmaceutical services. Proprietary Products and Others involving the new chemical entities, the differentiated formulations business and a dermatology specialty business. The company has a strategic partnership with Glaxo to market selected products across emerging markets outside India.
Stock Name Country Market Cap PE Ratio
Teva Pharmaceutical Industries (TEVA) Israel $19.350B 6.35
BridgeBio Pharma (BBIO) United States $4.392B 0.00
Bausch Health Cos (BHC) Canada $3.009B 2.18
Amphastar Pharmaceuticals (AMPH) United States $2.142B 12.88
Supernus Pharmaceuticals (SUPN) United States $1.978B 26.93
Taysha Gene Therapies (TSHA) United States $0.447B 31.14
Personalis (PSNL) United States $0.239B 0.00
Assembly Biosciences (ASMB) United States $0.094B 0.00
Sol-Gel Technologies (SLGL) Israel $0.013B 0.00
Evoke Pharma (EVOK) United States $0.007B 0.00
Teligent (TLGT) United States $0.000B 0.00